Hit enter after type your search item
Chemical World

At Alzheimer’s disease conference, lecanemab took center stage

By
/
On December 1, 2022
/
At 11:43 pm
/
In Chemical world
26 Views

Eisai addressed concerns over its monoclonal antibody drug candidate’s safety

You May Also Like
This div height required for enabling the sticky sidebar
Generated by Feedzy